Amin T.
- Country
- Germany
- Department
- 127602
Research Overview
- Efficacy and Safety of REGN7508 for Primary Prophylaxis of Cancer-Associated Thrombosis in Patients with Solid Tumors Undergoing Cancer Treatment
- Randomized phase II trial for patients with newly diagnosed low-risk multiple myeloma to evaluate the benefit of 6 cycles of isatuximab with lenalidomide/bortezomib/dexamethasone (I-VRD) followed by maintenance therapy with lenalidomide and isatuximab randomized in comparison with therapy consisting of 3 cycles of I-VRD followed by one cycle of high-dose therapy and maintenance therapy with lenalidomide and isatuximab
- Evaluation of Revumenib Combined with Azacitidine and Venetoclax in Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML Patients Ineligible for Intensive Chemotherapy
Data & Insights
Has run more than one trial at 60 of 311 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in treating blood-based cancers, with particular emphasis on multiple myeloma and acute myeloid leukemia. Their research activities focus on developing innovative therapeutic approaches for these challenging hematologic conditions.
- Multiple Myeloma Treatment Strategies
- AML Management in Treatment-Naive Patients
- Blood Cancer Therapeutics
Their work encompasses novel treatment combinations and targeted therapies for patients with specific genetic profiles.
Precision Medicine
The investigator focuses on expression-linked stratification and genetic mutation-based treatments, particularly in blood cancers. Their expertise includes developing personalized treatment approaches based on molecular markers.
- Molecular-Based Treatment Selection
- Genetic Profiling in Blood Cancers
- Targeted Therapeutic Approaches
Their research incorporates advanced diagnostic techniques including flow cytometry and next-generation sequencing.
Novel Therapeutic Combinations
The investigator explores innovative drug combinations in hematologic malignancies, with particular interest in evaluating new therapeutic agents in combination with established treatments.
- Combination Therapy Development
- Treatment Response Assessment
- Non-Intensive Treatment Approaches
Their work includes evaluation of minimal residual disease and overall survival outcomes in various treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.